Ezh2 Gain-Of-Function Mutations Are Not Associated With More Favorable Prognosis in Relapsed/Refractory Follicular Lymphoma (Fl): A Preliminary Analysis on 590 Patients
Hematological Oncology - United Kingdom
doi 10.1002/hon.6_2630
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley